| AgBio | AI/Software/eHealth | Analytical services |
| Antibodies | Anti-infectives | Bank fund |
| Bioinformatics | Biomaterials | Biosimilars |
| Business angel | Business development | CDMO/CMO (Contract Development/Manufacturing Organization) |
| Cell Therapy | Chemicals | Corporate investor |
| Cosmetics | CRO (Contract Research Organization) | Delivery devices |
| Dental devices | Diagnostic devices | Drug Delivery |
| Electro mechanical medical devices | Fill & finish | Food |
| Gene Therapy | Generics | Hospital |
| Imaging | Implantable devices | Incubator / Accelerator |
| Industry Association | Institute | Institutional investor |
| Laboratory equipment | Management consulting | Medical devices |
| Molecular diagnostics | News agency | Nucleic Acid Drugs |
| Nutraceuticals | Operation/Health &safety/Purchasing | Ophthalmic and optical devices |
| Packaging & labeling | Peptides | Private investor |
| Proteomics | Public fund | Quality control |
| Regenerative medicine | Reusable instruments | Sales & Marketing |
| Small molecules | Synthesis services | Technology transfer |
| University | Vaccines | Venture Capital Fund |
BIO KOREA 2023 Partners
